What's the difference between noncontagious and psoriasis?

Noncontagious


Definition:

  • (a.) Not contagious; not catching; not communicable by contact.

Example Sentences:

  • (1) Starting from 1978, noncontagious febrile diseases of unclear etiology, accompanied by pronounced headache, roseolous-papular eruptions, prolonged convalescence period, are registered in May-September in Astrakhan Province.
  • (2) The priority trend in the activity of health service is prevention of the principal noncontagious diseases, cardiovascular diseases being a major part among them.
  • (3) Ehrlichial organisms cause a disease called "ehrlichiosis," a noncontagious infectious disease known to be transmitted by a tick in several cases and by a fluke in one case.
  • (4) Self-help groups for individuals with sarcoidosis (a noncontagious multisystem disorder characterized by granulomas in many organs) are rare despite the physical and emotional problems associated with this disease.
  • (5) Because there is a high incidence of noncontagious disease in the elderly, they are the group most useful for the study of new therapeutic agents or procedures.
  • (6) It is possible that CJD could also occur sporadically as a noncontagious disease by a mechanism akin to oncogenes in carcinogenesis.
  • (7) Coccidioidomycosis is accepted as being noncontagious because the infectious arthroconidial form of Coccidioides immitis is not produced in humans and other mammalian hosts.
  • (8) Mycetoma is a localized noncontagious infection that involves cutaneous and subcutaneous tissue, fascia, and bone.

Psoriasis


Definition:

  • (n.) The state of being affected with psora.
  • (n.) A cutaneous disease, characterized by imbricated silvery scales, affecting only the superficial layers of the skin.

Example Sentences:

  • (1) We report the results of a double-blind, placebo-controlled trial of acitretin (Soriatane) in 15 patients with moderate to severe psoriasis.
  • (2) These findings suggest that Sch 40120 is a potent anti-inflammatory agent that may be particularly useful in the treatment of inflammatory diseases such as psoriasis in which leukotrienes appear to be major mediators of the pathological symptoms that characterize the disease state.
  • (3) Extracorporeal photopheresis (ExP) was administered every other week in an outpatient setting to four patients with chronic refractory psoriasis vulgaris without arthropathy.
  • (4) Utilizing the bilateral comparison technique in 30 hospitalized patients with chronic stable plaque-type psoriasis vulgaris, we closely monitored the clinical responses to ultraviolet radiation (Westinghouse fluorescent FS40 bulbs, 290--400 nm) and a variety of tar preparations and lubricant vehicles in combination and separately.
  • (5) It seems that the addition of liquid tar elevates the reaction threshold to dithranol in hypersensitive patients with psoriasis.
  • (6) The animal model of psoriasis was effectively treated by bimolane, both systemically and topically, and also by parenteral methotrexate and topical betamethasone valerate.
  • (7) A family history of psoriasis was obtained in 26% of first-degree relatives and 13% of second-degree relatives.
  • (8) Regarding psoriasis, emotional factors have a strong correlation with onset and flare-ups.
  • (9) Indeed, CsA may well represent a major advance in the understanding and treatment of psoriasis.
  • (10) These data demonstrate that monocytes from subjects with psoriasis are altered and suggest an apparent inherent metabolic disorder.
  • (11) Forty patients with psoriasis treated with methotrexate (MTX) are reviewed.
  • (12) In previous investigations we observed an increase of growth hormone (HGH) in the blood serum of patients suffering from various clinical forms of psoriasis.
  • (13) We conclude that there appears to be no benefit from exceeding a concentration of 5% crude coal tar in yellow soft paraffin in the treatment of patients with psoriasis and that the plateau in the dose-response curve for the action of crude coal tar in psoriasis begins at a point between 1 and 5%.
  • (14) Increasing evidence suggests an immunoregulatory function of the potent steroid hormone 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) which has been successfully applied for treatment of psoriasis.
  • (15) This group includes the typical ankylosing spondylitis as well as atypical spondylopathies such as those occurring in psoriasis, Reiter's disease and chronic inflammatory enteropathies, which attack mainly the spine and secondarily the peripheral joints.
  • (16) In this prospective study, 51 patients suffering from psoriasis and ichthyosis were treated with acitretin for 2 years.
  • (17) The object was to study the influence of concentration, contact time, psoriasis type, self-treatment at home, frequency of application, ointment base, and the admixture of corticosteroids on the efficacy of "minutes therapy."
  • (18) Recent epidemiological studies have suggested that psoriasis represents a risk factor for thrombotic vascular diseases.
  • (19) Psoriasis must be considered in the differential diagnosis of papulosquamous disorders in infants.
  • (20) These data suggest that platelet activation occurs in psoriasis, and that release of inflammatory and mitogenic compounds by activated platelets may play a role in the pathophysiology of psoriasis.

Words possibly related to "noncontagious"

Words possibly related to "psoriasis"